Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: re:cantwait...

After 20+ years of existence and 2+ years being exposed on the BB's (from it's initial run in 2006), we can safely say this stock is not an "unknown".

Assuming the patents come back in whole and unaffected, renewed interest will follow and will/May have a second life for investors...IMO there are many MANY eyes on us and how we faire.

The settlement affectively allows TPL/PTSC to keep the lights on, money in the bank and puts a lid on the internal expenses...

The USPTO ruling is THE far more significant corner and sets the tone for this company's destiny.

Regards

Share
New Message
Please login to post a reply